![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 43, 39629-39637, October 26, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*
§,
¶,
,
From the
Department of Chemistry, Bates College,
Lewiston, Maine 04240 and the ¶ Department of Biochemistry,
Medical College of Wisconsin, Milwaukee, Wisconsin 53226
Received for publication, March 26, 2001, and in revised form, August 20, 2001
| |
ABSTRACT |
|---|
|
|
|---|
The 3C proteases of the
encephalomyocarditis virus and the hepatitis A virus are both type III
substrates for the mammalian ubiquitin-protein ligase E3 The selection of proteins for destruction by the ubiquitin 26 S/proteasome pathway depends upon specific interactions that occur
between the targeted substrates and enzymes involved in the formation
of the ubiquitin-target protein conjugates. A hierarchical family of
pathways, each composed of at least three enzymes, accomplishes the
attachment of ubiquitin to proteins destined to be degraded (1-3).
Common to all of these pathways is the ubiquitin-activating enzyme,
E1,1 which recruits free
ubiquitin through the ATP-dependent formation of a
thiolester bond between a cysteine in the E1 and the C-terminal glycine
of the ubiquitin molecule. This ubiquitin is then transferred to one of
several members of the E2 family of proteins that are referred to as
ubiquitin carrier proteins or ubiquitin-conjugating enzymes. Finally,
the ubiquitin is transferred from the E2 to the target substrate
protein through the action of an ubiquitin-protein ligase, or E3.
Although each E2 protein appears to function with several specific
ubiquitin-protein ligases, each E3 can specifically interact with only
a limited number of substrate proteins. Regardless of the E3 involved
in the ubiquitination process, following the conjugation of the first
ubiquitin molecule to a primary amine on the substrate protein, the E3,
or the E3 plus E2 proteins, can catalyze additional conjugating
reactions that result in the synthesis of a chain of ubiquitin
molecules attached to the substrate (4).
Important unanswered questions remain as to precisely how the E3
ubiquitin-protein ligases recognize and interact with their substrate
proteins. It appears that proteins degraded by the ubiquitin/26 S
proteasome system contain structural features, often short primary sequence elements (2, 5), that act as protein destruction signals, and
presumably it is these structural features that serve as sites for
interaction with specific E3 proteins. Very few precisely mapped
protein destruction signal structures have been matched with their
cognate ubiquitin-protein ligase, however (2). Among the most well
studied E3 proteins are mammalian E3 E3 The recent development of an affinity chromatography purification
method, based upon the specific binding of mammalian E3 Construction of Plasmids Containing 3C Protease Coding
Sequences--
The construction of the expression plasmids
pETE3B'CD'*, pETHAV3C, and pETP3C have already been described
(21-23). pETE3CA38+, which contains the sequences
coding for the EMCV 3C protease with an alanine inserted between amino
acid positions 38 and 39, pETE3CL34A, pETE3CR39D, pETE3CK10,14R,
pETE3CK74,77R, and pETE3CK98,101R were prepared
using polymerase chain reaction-based oligonucleotide-directed mutagenesis. pE3C (23) was employed as a template, and DNA insert fragments containing the mutated EMCV 3C protease coding sequences were
synthesized using the appropriate mutagenic primer
(CTTGCCTCCTTGTGAGAGGCGCCCGCACCTTGGTAGTTAATAG for
pETE3CA38+, GAGGCCGCACCGCGGTAGTAAATAGACACATG for
pETE3CL34A, and CTTCTTGTGAGAGGCGACACCTTGGTAGTAAATAG for
pETE3CR39D). The inserts were ligated into pET3d at the
NcoI and BamHI sites (24). Likewise, the
expression plasmids pETHAV3CA37+, which contains the sequences coding for the HAV 3C protease with an alanine inserted between amino acid positions 37 and 38, and
pETHAV3CD37R were prepared using polymerase chain reaction.
pHAV3C (21) was employed as a template, and DNA insert fragments
containing the mutated HAV 3C protease coding sequences were
synthesized using the appropriate mutagenic primer
(CTTGGGAGTGAAAGATGATGGCTGGCTGCTTGTGCCTTC for pETHAV3CA37+,
and CACAAGCAGCCAACGATCTTTCACTCCCAAG for pETE3CD37R). The
inserts were ligated into pET3d. pETP3CN33R, which contains the sequences coding for a mutated poliovirus 3C protease, was constructed using pETP3C as a template. A DNA insert fragment containing the mutated poliovirus 3C protease coding sequence was
synthesized using the mutagenic primer
GGAGTCCACGACCGCGTGGCTATTTTACCAACC. The insert was ligated into pET3d at
the NcoI and BamHI sites.
Purification of E1, HsUbc2b, E3
The wild type EMCV 3C and mutated (3C(+A38), 3C(L34A), 3C(R39D),
3C(K10,14R), 3C(K74,77R), and 3C(K98,101R)) protease proteins were
expressed in E. coli from pETE3B'CD'*,
pETE3C+A38, pETE3CL34A, and
pETE3CR39D and were purified from refolded inclusion body material using procedures reported previously (22). Wild type HAV 3C
protease was expressed in E. coli from pETHAV3C and purified as described previously (21). The mutated HAV 3C(+A37) and 3C(D37R) proteins were expressed from pETHAV3CA37+ and
pETE3CD37R, but the presence of the mutations necessitated
an altered purification scheme. Cleared lysates from induced cells were
passed through a Q-Sepharose column (Amersham Pharmacia Biotech)
equilibrated in TDE buffer (50 mM Tris-HCl, pH 7.6, 1 mM dithiothreitol, and 0.1 mM EDTA) containing
0.1 mM phenylmethylsulfonyl fluoride. The bound 3C protease
proteins were eluted with a gradient of 300 to 650 mM NaCl
in TDE buffer. The column fractions containing the 3C protease proteins
were fractionated further and concentrated by precipitation with 30 to
50% (NH4)2SO4. The precipitates
were resuspended in 10 mM
KH2PO4-K2HPO4, pH 6.9, and applied to a column of Bio-Gel HTP hydroxyapatite (Bio-Rad)
equilibrated in the same buffer. Bound material was eluted with a step
gradient of 100 to 300 mM
KH2PO4-K2HPO4, pH 7.2. The eluted proteins were dialyzed against TDE buffer containing 10%
glycerol. Stock solutions of the 3C protease preparations were prepared
to be
All of the purified 3C protease proteins, with the exception of the
wild type EMCV 3C protease, have an N-terminal methionine instead of
the naturally occurring glycine or serine residues found in the mature
proteins. The non-mutated EMCV 3C protease expressed in E. coli from pETE3B'CD'* undergoes self-processing to produce a
protein with a glycine residue at the N terminus (22). For convenience,
both non-mutated proteins are referred to here as wild type proteins.
Measurements of the Rates of 125I-Ubiquitin-3C
Protein Conjugate Formation and Km and Vmax
Determinations--
Bovine ubiquitin (Sigma) was purified further to
apparent homogeneity (28) and radioiodinated by the Chloramine T
procedure (14). Some of this material was subjected to reductive
methylation (29). The initial rates of 125I-ubiquitin
conjugation were measured using an adaptation of methods employed
previously (20). The reaction mixtures typically contained, in a final
volume of 25 µl, 50 mM Tris-HCl, pH 7.5, 10 mM MgCl2, 10 mM creatine phosphate,
2 mM ATP, 1 mM dithiothreitol, 1 international unit/ml creatine phosphokinase (Sigma), 1 international unit/ml high
protein liquid chromatography-purified yeast inorganic pyrophosphate (Sigma), 50 nM purified E1, 500 nM purified
HsUbc2b, 0.2 µg of affinity-purified E3
Reaction rate data sets were generated by measuring the initial rates
of monoubiquitinated conjugates produced in several simultaneously
incubated reaction mixtures containing varying concentrations of 3C
protease substrate. Two to four data sets were generated for each
substrate protein using the same preparations of E1, HsUbc2b, and
E3 Evaluation of the Susceptibility of Poliovirus 3C Protease
Proteins toward Conjugation with Ubiquitin in Reticulocyte
Lysate--
A coupled in vitro transcription-translation
rabbit reticulocyte system (Promega) was employed to prepare
35S-labeled poliovirus 3C and 3C(N33R) proteins encoded
within pETP3C and pETP3CN33R. The ability of these proteins
to serve as substrates for ubiquitination was evaluated by incubating 7 µl of transcription-translation reaction mixtures in a final volume
of 20 µl containing 20 mM HEPES-KOH, pH 7.5, 1 mM dithiothreitol, 0.1 mM methylated ubiquitin, 0.1 mg/ml cycloheximide, and 60% by volume reticulocyte lysate containing an energy-generating system at 30 ° for 40 min (21-23). Aliquots of the reaction mixtures were analyzed by 12% SDS-PAGE and fluorography.
Kinetic Characterization of E3
A comparison of the labeled products generated by the reconstituted
system with either
For each kinetic analysis, the quantity of 125I-ubiquitin
incorporated into monoubiquitinated conjugates during the 15-min
incubation period was measured as a function of 3C-protease
concentration. An example of the SDS-PAGE gel analysis from a set of
reaction mixtures used in measuring the rate of conjugation of
ubiquitin to the wild type EMCV 3C protease is shown in Fig.
1B. The range of concentrations of some of the 3C protease
proteins employed in these measurements did not produce initial
velocities that approach saturation, which has the potential to
introduce error into the calculations of kinetic parameters. Higher
substrate concentrations would, however, have required the use of stock 3C protease preparations at concentrations we have observed to sometimes result in the formation of aggregates during long term storage. Despite this limitation to the reaction conditions, the reproducibility of the velocity versus substrate
concentration measurements supports the reliability of the data. Fig.
1C shows the simultaneous fit of initial velocity
versus substrate concentration data from four sets of
measurements using the EMCV 3C protease. As with all of the 3C proteins
employed in this study for which rate measurements could be made, the
dependence of the initial ubiquitin attachment rate upon substrate
concentration exhibited hyperbolic kinetics. This is confirmed by the
linearity of the data in the double reciprocal plots, demonstrated in
Fig. 1D. The random distribution of the plotted residuals
versus the theoretical fit of the data (Fig. 1, C
and D) are consistent with the Michaelis-Menten analysis
used here to determine the kinetic parameters. The
Km and Vmax values for the
conjugation of ubiquitin to the substrate proteins were calculated
using non-linear least squares fit analysis of the velocity
versus substrate concentration data, as described under
"Experimental Procedures."
Both the wild type 3C proteases and 3C proteases containing mutations
in the protein destruction signal sequence were evaluated as E3
Measurements of the initial rates for the E3
The Km and Vmax values for
attachment of the first ubiquitin to the wild type 3C proteases
(42 ± 11 µM and 0.051 ± 0.01 pmol/min,
respectively, for the EMCV 3C proteases and 20 ± 5 µM and 0.018 ± 0.003 pmol/min, respectively, for
the HAV 3C proteases) are of similar orders of magnitude as those
reported for other substrates of mammalian E3
Although the differences between the Km and
Vmax values for the wild type and mutated 3C
proteases are not large, they likely reflect genuine differences in the
interactions between these proteins and E3
Attempts were made to measure the rate at which E3 Effects of Selected Lysine to Arginine Substitutions on the
Kinetics of E3
The initial rates at which these mutated proteins are ubiquitinated in
the E3 E3 We have used a kinetic approach to examine the interaction of
affinity-purified human ubiquitin-protein ligase E3 Rate measurements in a reconstituted system under E3 Mutations in the destruction signal sequences of both the EMCV and HAV
3C proteases alter the kinetics with which these proteins undergo
E3 The Vmax/Km ratios for the
ubiquitination of the 3C proteases in the reconstituted reaction system
are similar, and this provides insights into the mechanistic behavior
of E3 The low Vmax, and therefore low
kcat, values that characterize the
E3 The kinetic analysis of the E3 Our analysis of the kinetics of the ubiquitination of the EMCV and HAV
3C proteases indicate that E3
. The
conjugation of ubiquitin to these proteins requires internal ten-amino
acid-long protein destruction signal sequences. To evaluate how these
destruction signals modulate interactions that must occur between E3
and the 3C proteases, we have kinetically analyzed the formation of
ubiquitin-3C protease conjugates in a reconstituted system of purified
E1, HsUbc2b/E214Kb, and human E3
. Our
measurements show that the encephalomyocarditis virus 3C protease is
ubiquitinated in this system with Km = 42 ± 11 µM and Vmax = 0.051 ± 0.01 pmol/min whereas the parameters for the ubiquitination of the
hepatitis A virus 3C protease are Km = 20 ± 5 µM and Vmax = 0.018 ± 0.003 pmol/min. Mutations in the destruction signal sequences resulted in
changes in the rate at which E3
conjugates ubiquitin to the altered
3C protease proteins. The Km and
Vmax values for these reactions change
proportionally in the same direction. These results suggest differences
in rates of conjugation of ubiquitin to 3C proteases are primarily a
kcat effect. Replacing specific
encephalomyocarditis virus 3C protease lysine residues with
arginine residues was found to increase, rather than decrease, the rate
of ubiquitin conjugation, and the Km and
Vmax values for these reactions are both higher
than for the wild type protein. The ability of E3
to catalyze the
conjugation of ubiquitin to both 3C proteases was found to be inhibited
by lysylalanine and phenylalanylalanine, demonstrating that the same
sites on E3
that bind destabilizing N-terminal amino acids in type I
and II substrates also interact with the 3C proteases.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
, which functions in conjunction
with the ubiquitin carrier protein HsUbc2 (E214K; see Refs.
6 and 7), and the yeast homologue of E3
, Ubr1p, which requires the
presence of yeast Ubc2p/Rad6 ubiquitin carrier protein (8, 9). E3
and Ubr1p were first shown to recognize proteins with N-terminal basic
(type I) or bulky hydrophobic (type II) amino acids as substrates
(10-16). Based on the affinity resin binding behavior of E3
(13),
measurements of the degradation rates of artificial substrates in
reticulocyte lysate and in intact yeast cells (7, 12), and in
vitro and in vivo dipeptide competition studies (11,
13, 14), it was proposed that these enzymes contain both type I and
type II N-terminal amino acid binding sites (13, 15, 16). These binding
sites were assumed to provide the means by which substrate proteins are
recognized by E3
and Ubr1p. In recent years it has been discovered
that E3
and Ubr1p can catalyze the ubiquitination of proteins
lacking destabilizing N-terminal amino acids (type III substrates). The short-lived yeast proteins Gpap and Cup9p, neither of which contains a
destabilizing N-terminal amino acid, have been reported to be substrates for Ubr1p (17-19). Ribonuclease S, the subtilisn-derived fragment of ribonuclease A, has a stabilizing serine N terminus, but it
is known to be a substrate for mammalian E3
-dependent ubiquitin-protein conjugate synthesis (20). This indicates these E3
enzymes can recognize substrate proteins through associations with
other types of structural elements.
has recently been found to catalyze the conjugation of ubiquitin
to two additional proteins that, based upon their N-terminal amino
acids, would not be predicted to be N-end rule substrates for
degradation. The 3C proteases produced by the encephalomyocarditis virus (EMCV) and the hepatitis A virus (HAV), both members of the
picornavirus family, have been shown to serve as substrates for
E3
-dependent ubiquitination
(21-23).2 The ten-amino acid
sequence 34LLVRGRTLVV43, located in what is
probably a strand-turn-strand structure, has been discovered to
function as a protein destruction signal in the EMCV 3C protease (22).
The HAV 3C protease contains the sequence
32LGVKDDWLLV41 in a location homologous to that
of the EMCV protein destruction signal sequence, and this sequence has
been shown to be required for the ubiquitination and degradation of the
HAV 3C protein (21, 23).3 The
identification of two substrate proteins recognized by E3
, both of
which contain precisely mapped, internal sequences known to be required
for E3
-dependent ubiquitin conjugation, provides excellent model systems for detailed studies of the interactions that
take place between E3
and substrate proteins lacking a destabilizing N-terminal amino acid.
to
HsUbc2b,4 has made it
possible to obtain sufficient quantities of pure E3
to allow
biochemically defined kinetic studies of the E3
-catalyzed conjugation of ubiquitin to different types of substrate proteins (20).
We have used a reconstituted system of purified E1, HsUbc2b, and
affinity-purified human E3
to evaluate the kinetics of the conjugation of ubiquitin to the EMCV and HAV 3C proteases. We have
determined the Km and Vmax
values for the E3
-dependent conjugation of ubiquitin to
the wild type 3C proteases and to 3C protease proteins containing
mutations in their defined, internally located protein destruction
signal regions. The kinetics with which EMCV 3C proteases containing
selected lysine to arginine substitutions are ubiquitinated were also
evaluated. Our results indicate that differences in the ability of the
3C proteases to serve as substrates for E3
are most likely the
result of differences in the kcat values with
which the catalysis of ubiquitin conjugation occurs. We also obtained
data demonstrating that the interaction of E3
with the 3C protease
proteins involves the same site, or sites, with which it associates
with both basic and hydrophobic destabilizing N-terminal amino acids.
Our findings explicate the ability of E3
to target non-N-end rule
substrates for degradation and reveal that the mechanism by which the
ubiquitin-protein ligase E3
selects substrate proteins for
ubiquitination is considerably more complicated than suggested by
earlier studies.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
, and EMCV and HAV 3C Protease
Proteins--
Human erythrocyte fraction II was prepared using
procedures described previously (25). Human ubiquitin-activating enzyme E1 was purified from this material using a ubiquitin affinity column
and fast protein liquid chromatography methods described previously
(26). Human recombinant HsUbc2b (27) was expressed in
Escherichia coli and purified using methods reported
previously (20). Some of this protein was employed in the preparation
of an affinity column, which was then used to purify ubiquitin-protein ligase E3
from the fraction II preparation as reported recently (20).
2 mg/ml. We have observed that at least some of the 3C
proteins form aggregates, detectable by size exclusion chromatography,
during long term storage at greater concentrations than this.
preparation, 0 to 20 µM exogenous protein substrates, and 4 µM
125I-ubiquitin or 125I-methylated ubiquitin
(about 12,000 cpm/pmol). The mixtures were incubated for 15 min at
37 ° and then boiled for 4 min in the presence of 25 µl of added
sample buffer. This incubation time was selected to yield a linear
initial rate of monoubiquitination. The samples were analyzed by 12%
SDS-PAGE and autoradiography. The amounts of monoubiquitin-substrate
protein conjugates formed were determined by cutting slices from the
dried gels and subjecting them to
-counting (30). Control
experiments confirmed that the initial rate was linear with
[E3
]0 and independent of [E1]0 or
[HsUbc2b]0 (20).
. The rate versus substrate concentration data sets
were simultaneously fit for each substrate to the Km value using a non-linear least squares regression analysis program (Sigma Plot 5.0). The Vmax values for each
substrate were calculated by averaging the values derived from the fits
for each data set.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-catalyzed Conjugation of
Ubiquitin to the 3C Proteases and to 3C Proteases with Protein
Destruction Signal Mutations--
Under appropriate conditions,
kinetic analysis provides a sensitive and accurate means of quantifying
enzyme-substrate interactions and the catalytic competence of the
resulting Michaelis complex. We employed a biochemically defined,
reconstituted N-end rule ubiquitin ligation system, comprised of
affinity-purified human E1 and E3
and recombinant human HsUbc2b, to
quantitatively evaluate the targeting of the EMCV and HAV 3C proteases
for ubiquitin attachment and to assess the effect disrupting their
respective destruction signal sequences has on their selection as N-end
rule pathway substrates.
-lactalbumin or wild type EMCV 3C protease as the
substrate is shown in the autoradiogram in Fig. 1A, lanes 1-3. In
the absence of a substrate protein, the otherwise complete assay
mixture containing E1, HsUbc2b, and E3
catalyzes the synthesis of
hyperconjugates to trace protein contaminants in the enzyme
preparations, seen at the top of lane 1 (see Fig. 1A and Ref. 20). Monoubiquitin-HsUbc2b conjugates are also
generated under these conditions, at the concentration of this enzyme
employed to assure E3
-limiting conditions. In reaction mixtures in
which
-lactalbumin was the substrate most of the products
synthesized during the incubation period were high molecular mass
polyubiquitin-
-lactalbumin conjugates, and the characteristic ladder
of sequential ubiquitin adducts is apparent (Fig. 1A,
lane 2). The conjugation of ubiquitin to the EMCV 3C
protease occurred at a markedly lower rate, and the majority of these
products consisted of monoubiquitinated 3C protease (Fig.
1A, lane 3). The rate of monoubiquitin-3C
protease synthesis was found to be linear for up to 15 min. An
increasingly large fraction of the products consisted of
polyubiquitinated 3C protease at longer times (data not shown). This
suggests the attachment of the first ubiquitin molecule to the 3C
protease occurs more slowly than subsequent polyubiquitinated conjugate synthesis. It should be noted that the synthesis of polyubiquitinated
-lactalbumin conjugates has been shown to also be linear with respect to time and E3
concentration in a reaction system very similar to the one used here (20). Because our goal in this study was
to attempt to detect potentially subtle differences in the kinetics
with which related substrate proteins are ubiquitinated by the same
ubiquitin-protein ligase, we preferred to avoid artifacts that might
result from the use of ubiquitin mutants or derivatives that do not
support polyubiquitin chain synthesis. In addition, the rate of the
first ubiquitin attachment is more likely than subsequent steps to
reflect substrate recognition events mediated by E3
. To confirm that
the formation of polyubiquitinated 3C protease was not a major event
during the incubation time, reactions were carried out in which
125I-methylated ubiquitin was used in place of
125I-ubiquitin. Measurements of the fraction of the total
labeled 3C protease-dependent products that migrated in
SDS-PAGE gels above the methylated ubiquitin-3C protease (Fig.
1A, lanes 4 and 5) were found to be
virtually identical to the fraction of analogous material synthesized
in reaction mixtures containing 125I-ubiquitin. This
indicates the amount of monoubiquitinated 3C protease present in the
reaction mixtures at the end of 15 min is not significantly affected by
reactions that lead to the synthesis of polyubiquitinated 3C protease.
Identical results were obtained using the HAV 3C protease as a
substrate. The rate of formation of monoubiquitinated 3C protease
proteins was therefore taken to be a valid measure of the initial rate
at which E3
catalyzes the conjugation of the first ubiquitin to
these substrates.

View larger version (42K):
[in a new window]
Fig. 1.
The kinetic analysis of the
E3
-dependent synthesis of
ubiquitin-EMCV 3C protease conjugates in the reconstituted reaction
system. A, analysis of reaction mixtures containing
-lactalbumin or the wild type EMCV 3C protease as substrates.
Reconstituted reaction mixtures containing either
125I-ubiquitin (lanes 1-3) or
125I-methylated ubiquitin (lanes 4 and
5) were incubated for 15 min in the presence of no added
substrate (lanes 1 and 4), 10 µM
-lactalbumin (lane 2), 10 µM wild type EMCV
3C protease (lane 3), or 20 µM wild type EMCV
3C protease (lane 5) and then aliquots were removed and
analyzed by 12% SDS-PAGE and autoradiography. The mobility of labeled
monoubiquitin- and methylated ubiquitin-3C protease (mono
Ub-3C and MeUb-3C) and monoubiquitin- and methylated
ubiquitin-HsUbc2b (mono Ub-HsUbc2b and
MeUb-HsUbc2b) conjugates is indicated. B,
analysis of reaction mixtures containing different concentrations of
the wild type EMCV 3C protease. Reconstituted reaction mixtures
containing the indicated amounts of EMCV 3C protease as the substrate
were incubated for 15 min and then aliquots were removed and analyzed
by 12% SDS-PAGE and autoradiography. The samples analyzed are as
follows: lane 1, no 3C protease added; lane 2, 4 µM 3C protease; lane 3, 8 µM 3C
protease; lane 4, 12 µM 3C protease;
lane 5, 16 µM 3C protease; lane 6,
20 µM 3C protease. The location of labeled
monoubiquitinated 3C protease, monoubiquitinated HsUbc2b, and
diubiquitin (diUb) are indicated. C,
simultaneously fitted plots of initial reaction velocity
versus wild type EMCV 3C protease concentration from four
separate experiments. The data were fitted using non-linear least
squares regression analysis. D, reciprocal plots of the data
sets graphed in panel C. Plots of the residuals
versus the theoretical fit of the data in C and
D are shown in the lower panels.
substrates. The wild type protein destruction signal region sequences
and the sequences present in the mutated proteins used in this study
are shown in Fig. 2. The L34A and +A38
mutations in the EMCV 3C protease were selected, because proteins
carrying these changes have been shown previously to serve as poor
substrates for the ubiquitin/26 S proteasome system in rabbit
reticulocytes (23). The leucine residue occupying the first position of
the sequence has been shown to be particularly important for signal function, as has the distance separating the hydrophobic amino acid
triplets on either end of the signal sequence. The +A37 mutation in the
HAV 3C protease was prepared, because we wished to evaluate the
kinetics of an HAV 3C protein carrying a mutation we predicted would
render the protein a poor E3
substrate by increasing the distance
between the distal hydrophobic residues in the destruction signal
sequence. The HAV 3C(D37R) mutant was prepared to provide a substrate
for testing the effects of replacing one of the two negatively charged
amino acids in the HAV 3C protease destruction signal with a positively
charged amino acid. This mutated protein carries an arginine residue in
the same relative position as the Arg-39 residue in the wild type EMCV
3C protease signal sequence. To serve as a complement for this
substrate, the EMCV 3C(R39D) protein was also prepared.

View larger version (30K):
[in a new window]
Fig. 2.
The protein destruction signal sequences in
the wild type and mutated EMCV and HAV 3C protease proteins.
w.t., wild type.
-dependent
conjugation to the wild type and mutated EMCV and HAV 3C proteases were
used to calculate the Km and
Vmax values for the reactions with each
substrate. The values of the kinetic parameters are displayed, for ease
of comparison in Fig. 3A
(open bars for Km values, and
shaded bars for Vmax values), and a
comparison of the Vmax/Km
ratios is presented in Fig. 3B. Because the same
concentration of E3
was used in all of the reaction mixtures,
Vmax can be assumed to be proportional to
kcat, and Vmax/Km can be employed for
comparing catalytic efficiencies with which E3
conjugates ubiquitin
to the 3C protease substrates. Also for comparison, an SDS-PAGE
analysis of the products generated in reactions containing
-lactalbumin and the 3C proteases is shown in Fig. 3C.
Again,
-lactalbumin was rapidly incorporated into primarily large
polyubiquitinated conjugates, whereas the ubiquitinated wild type 3C
protease products were synthesized more slowly and included mostly
monoubiquitinated conjugates. Differences in the quantity of
monoubiquitinated 3C protease products synthesized during the
incubation period are evident.

View larger version (36K):
[in a new window]
Fig. 3.
The kinetic parameters for the
E3
-dependent conjugation of
ubiquitin to wild type EMCV (WT) and HAV 3C protease
proteins and to 3C proteins containing mutations in the destruction
signal regions. A, bar graph of the
Km and Vmax values calculated
from the rate measurements for the ubiquitination of the 3C protease
proteins in the reconstituted reaction system. Open bars
correspond to the Km values, and shaded
bars correspond to the Vmax values.
B, bar graph of the
Vmax/Km values for the
reactions with each substrate protein. C, analysis of
reaction mixtures containing
-lactalbumin, wild type 3C proteases,
or mutated 3C protease substrates. Reconstituted reaction mixtures
containing 10 µM each substrate protein were incubated
for 15 min, and aliquots were removed for analysis by 12% SDS-PAGE and
autoradiography. The positions of the monoubiquitinated 3C protease
conjugates are indicated by the arrows.
(20). Changes in the
protein destruction signal sequences of both 3C proteases were found to have measurable effects on the kinetics with which these proteins are
ubiquitinated. Both the Km and
Vmax values for the attachment of the first
ubiquitin to the EMCV 3C(+A38) and EMCV 3C(L34A) proteases were found
to be reduced relative to the values calculated for the reactions with
the wild type protein (Fig. 3A). An example of the
simultaneous fit of the initial velocity versus substrate
concentration data for one of the EMCV 3C protease destruction signal
mutants, 3C(+A38), is shown in Fig. 4. In
this case, the reaction does approach saturation at the higher
concentrations of substrate. The HAV 3C(+A37) protease was such a poor
substrate for E3
(evident from the results shown in Fig.
3C) that reliable initial rate measurements were not
possible. These results are consistent with the earlier
characterization of the 3C protease destruction signal (23). The
reactions with the HAV 3C(D37R) protease occurred with
Km and Vmax values both
severalfold larger than the corresponding wild type substrate
parameters (Fig. 3A). Although the data clearly indicate the
D37R mutation results in large increases in Km and
Vmax for the ubiquitination of the protease, the
high parameter values mean that the substrate concentrations in the
reaction mixtures were far from saturating. These values therefore have
a relatively large associated uncertainty. These results nevertheless
indicate that a basic amino acid in this position positively affects
interactions between the destruction signal region and E3
. The
complementary reverse mutation in the EMCV 3C(R39D) protein did not,
however, lead to a reduction in the kinetic parameter values. This
substrate was ubiquitinated in the reconstituted system with
Km and Vmax values similar to
those for the wild type protein (Fig. 3A). As Fig.
3B shows, the
Vmax/Km ratios for the
ubiquitination of the wild type and mutated 3C proteases are
similar.

View larger version (10K):
[in a new window]
Fig. 4.
The kinetic analysis of the
E3
-dependent synthesis of
ubiquitin-EMCV 3C(+A38) protease conjugates in the reconstituted
reaction system. Velocity versus wild type EMCV
3C(+A38) protease concentration measurements from two separate
experiments were simultaneously fitted using non-linear least squares
regression analysis. A plot of the residuals versus the
theoretical fit of the data is shown in the lower
panel.
. A previously published
demonstration that mutations in the destruction signal region of the
EMCV 3C protease can interfere with the E3
-catalyzed ubiquitination
of this protein (23) supports the quantitatively derived results
obtained here. It is unlikely the kinetic differences are due, for
example, to the variable presence of small amounts of nicked or
truncated species in the protein preparations that resulted in the
exposure of types I or II substrate N-terminal amino acids. The same
preparations of E1, HsUbc2b, E3
, and energy system enzymes were used
for all of the measurement reported here. Two different preparations of the wild type HAV 3C protease were used in the rate measurements performed for this study, and both were ubiquitinated with very similar
kinetic parameters. This indicates that if contamination of the
protease preparations occurs, it occurs in a reproducible fashion. If
the 3C proteases are nicked by proteases during purification, it seems
likely that peptide bond cleavage would occur in the same locations and
with similar frequencies in both the wild type and mutated protein
preparations. Finally, the dramatic reduction in the rate of
ubiquitination of the HAV 3C protease caused by the +A37 mutation was
not accompanied by the obvious synthesis of any other ubiquitin-protein
conjugates (Fig. 3C), making it appear unlikely that
competition with better E3
substrate contaminants is a significant factor.
catalyzes the
conjugation of ubiquitin to the wild type poliovirus 3C protease, but
these were unsuccessful. The poliovirus 3C protease has been shown to
be a very poor substrate for the ubiquitin/26 S proteasome system (21).
The poliovirus 3C protease contains, in a position analogous to that of
the EMCV and HAV 3C protease destruction signal sequences, the sequence
28LGVHDNVAIL37 (23). Given the results obtained
with the HAV 3C(D37R) and EMCV 3C(R39D) proteins, we wondered whether
replacing the asparagine residue at position 33 with an arginine would
by itself substantially improve the ability of the poliovirus 3C
protease to serve as a substrate for the purified E3
. An arginine
residue in this position aligns with both the Arg-39 in the wild type
EMCV 3C protease and with the arginine residue substituted into the HAV 3C(D37R) protein (see Fig. 2). Attempts to refold the mutated poliovirus protein from inclusion bodies obtained from expressing E. coli cells were unsuccessful. The poliovirus 3C(N33R)
protein was, therefore, instead prepared by in vitro
translation, and its ability to serve as a substrate for conjugation
with ubiquitin was tested using rabbit reticulocyte cell extracts
supplemented with methylated ubiquitin (21-23). The results of these
experiments showed that the N33R substitution had little or no effect
on the susceptibility of the poliovirus 3C protein toward
ubiquitination (data not shown). Although this result does not prove
conclusively that E3
fails to interact easily with the poliovirus
3C(N33R) protein, it does suggest that a basic amino acid in this
position does not in itself generate a functional protein destruction signal.
-catalyzed Ubiquitination of EMCV 3C
Proteases--
The EMCV 3C protease contains twelve lysine
residues, none of which occur in the destruction signal sequence, and
it as been shown that any of these amino acids can serve as the initial
ubiquitin-conjugating site (23). It is conceivable that the location of
lysine residues in a substrate protein, relative to a protein
destruction signal for example, can influence the likelihood with which
they are selected by ubiquitin-protein ligases (16, 31). To determine whether eliminating some of the potential ubiquitin attachment sites in
the EMCV 3C protease changes the kinetics with which E3
catalyzes
the ubiquitination of this protein, we prepared three EMCV 3C protease
proteins that each contain two lysine to arginine substitutions. Based
upon sequence alignments with the HAV 3C protease and examinations of
the HAV 3C protease three-dimensional structure (32-34), we selected
substitution sites likely to exist in separate locations on
approximately the same face of the EMCV 3C protein as does the protein
destruction signal region. These proteins, EMCV 3C(K10,14R),
3C(K74,77R), and 3C(K98,101R), have been shown previously to retain
levels of catalytic activity similar to the wild type 3C protease,
indicating these mutations do not induce significant higher order
structural alterations (23).
-dependent ubiquitin-conjugating system were greater than for the wild type protein (Fig.
5), leading to increases in both
Km and Vmax in each case.
Although these results provide a clear indication that all three
mutations led to a similar effect on the kinetics with which the EMCV
3C protease is ubiquitinated, the calculated Km and
Vmax values contain much larger standard errors,
because the Km values are beyond the concentration
ranges possible for the 3C protease substrates.

View larger version (15K):
[in a new window]
Fig. 5.
The kinetic parameters for the
E3
-dependent conjugation of
ubiquitin to EMCV 3C protease proteins containing lysine to arginine
substitutions. The bar graph shows the
Km and Vmax values calculated
from the rate measurements for the ubiquitination of the 3C protease
proteins in the reconstituted reaction system. Open bars
correspond to the Km values, and shaded
bars correspond to the Vmax values.
WT, wild type.
Recognizes the 3C Proteases as N-end Rule Substrates--
A
characteristic feature of E3
ligase is its inhibition by dipeptides
containing cognate N-end rule residues in the N-terminal position (8,
10, 11). It was demonstrated recently that this effect follows classic
non-competitive inhibition (20), suggesting that the association of
substrates with E3
involves a site in the ligase distinct from the
site that recognizes N-terminal amino acids. We tested whether the EMCV
and HAV 3C proteases behave as N-end rule substrates, as defined by the
effect dipeptides have on the E3
-dependent synthesis of
ubiquitin-3C protease conjugates. As shown by the data in Fig.
6, both lysylalanine and
phenylalanylalanine inhibited the conjugation of ubiquitin to both wild
type 3C protease proteins. The ubiquitination of the HAV 3C protease is
more strongly inhibited by the dipeptides, especially lysylalanine,
than is the EMCV 3C protease. This is probably a reflection of the
significant differences in the sequences of these two proteins (32,
33), which in turn affects the stability of least one of the 3C
protease-E3
interactions that must occur during the
ubiquitin-conjugating mechanism. The inhibitory effects evident when
the control dipeptides alanyllysine and alanylphenylalanine were
present in the reaction mixtures are because of a reduction in the
steady state formation of the activated ubiquitin-E1 thiolester complex
(20).

View larger version (13K):
[in a new window]
Fig. 6.
Effect of dipeptides on the
E3
-dependent conjugation of
ubiquitin to the wild type EMCV and HAV 3C proteases.
Reconstituted reaction mixtures containing 10 µM wild
type 3C protease were incubated for 15 min in the presence of various
concentrations of dipeptide. Aliquots were removed from the mixtures
and analyzed by SDS-PAGE, and the quantity of 125I-labeled
monoubiquitin-3C protease conjugates produced was determined. For each
reaction, the quantity of conjugates formed in the absence of dipeptide
was taken to be 100% of maximum activity. A, plots showing
the synthesis of conjugates in the presence of the wild type EMCV 3C
protease. B, plots showing the synthesis of conjugates in
the presence of the wild type HAV 3C protease. Legends for both plots
are as follows:
, conjugate synthesis in the presence of
alanyllysine;
, conjugate synthesis in the presence of lysylalanine;
, conjugate synthesis in the presence of alanylphenylalanine;
,
conjugate synthesis in the presence of phenylalanylalanine.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
with two naturally occurring N-end rule substrate proteins, the 3C proteases produced by the picornaviruses EMCV and HAV. Both of these proteins behave as type III substrates, because neither has a destabilizing N-terminal basic or bulky hydrophobic amino acid (12, 14). Both
proteins have instead internal ten-amino acid-long regions that serve
as protein destruction signals required for the E3
-catalyzed conjugation of ubiquitin (21, 23).3
-limiting
conditions were used to calculate the kinetic parameters for the
E3
-catalyzed ubiquitination of the wild type EMCV and HAV 3C
proteases and 3C proteases containing mutations in the protein destruction signal regions. Conjugation of wild type EMCV 3C protease shows saturation kinetics with a Km of 42 ± 11 µM and a Vmax of 0.051 ± 0.01 pmol/min whereas the HAV 3C protease is ubiquitinated with a
Km of 20 ± 5 µM and a
Vmax 0.018 ± 0.003 pmol/min. That the
conjugation of ubiquitin to these proteins occurs with dissimilar
kinetics is not surprising, given that these picornavirus protease
orthologs do not share a high degree of sequence homology, and their
destruction signal sequences are dissimilar (23, 32, 33), presumably
reflected in the different kinetics of E3
ligation. The initial
rates with which the 3C proteases are ubiquitinated in the
reconstituted system were found to be much lower than for the type I
N-end rule substrate
-lactalbumin (20), and the major product formed
was the monoubiquitinated 3C protease adduct.
-dependent ubiquitination. Replacing the first leucine in the EMCV 3C protease destruction signal sequence with alanine or
increasing to five the number of amino acids in the central regions of
both the EMCV and the HAV 3C protease signal sequences resulted in
proteins ubiquitinated by E3
with lower Km and
Vmax values than the wild type proteins. Such
mutations in the destruction signal sequence reduce the ability of
these proteins to serve as substrates for ubiquitination in
reticulocyte lysate (23). An attempt was made to demonstrate that a
basic amino acid located in the third position in the central
hydrophilic region of the destruction signal sequence enhances signal
function in the E3
reaction system. Although the replacement of the
aspartate at position 37 in the HAV 3C protease with an arginine
resulted in an increase in the E3
-dependent rate of
ubiquitination and increases in both the Km and
Vmax for the reaction, the results of
experiments with the EMCV 3C(R39D) and poliovirus 3C(N33R) proteases do
not support the conclusion that a basic amino acid in this position is
a required component of a functional destruction signal. Given that the
3C protease destruction signal is located in a stand-turn-strand motif
(23, 34), it is conceivable that higher order structure plays a role in
the recognition of these proteins by E3
. It is of interest to note
that all of the mutations that resulted in reduced
Km and Vmax values for
ubiquitin attachment have also been found to reduce or eliminate the
catalytic activities of the EMCV and HAV 3C
proteases.5 Because the
destruction signals are located near the catalytic site in both
proteins, the effects of the mutations on the reaction kinetics
observed here may be due, at least in part, to higher order structural alterations.
. If it is assumed E3
acts upon these substrates in a
non-equilibrium, sequential reaction process that can be described by
the classic two-step binding and catalysis mechanism, so that
Vmax = kcat[Etotal], Km = (k
1 + kcat)/k1, and it is
assumed k
1 < kcat,
then differences in kcat will affect both the
Vmax and the Km
proportionally and in the same direction, as observed for the 3C
protease substrates. Substrate-dependent variations in
k1 or k
1 may occur, but
these would have to always complement each other in a way that would
have a small impact on the Km value, and this is
unlikely. The simplest interpretation of the data is that the
differences in the rates at which E3
catalyzes the initial
attachment of ubiquitin to the 3C proteases are the results of
mechanistic events that occur subsequent to the initial recognition of
the substrate proteins by E3
. It is possible that enzymatic steps
following the initial ubiquitination reaction monitored here can impact
the kinetics with which the first reaction occurs, especially if a
significant portion of the available E3
is involved in the synthesis
of polyubiquitinated 3C protease conjugates. Because the synthesis of
monoubiquitinated 3C protease conjugates is rate-limiting, and the rate
measurements were made prior to the formation of significant amounts of
polyubiquitinated products, however, these downstream reaction events
should not compromise our interpretation of the data.
-dependent ubiquitination of the 3C proteases in the reconstituted reaction system are not without precedent. The
Vmax for the ubiquitination of ribonuclease S,
another type III N-end rule substrate, by E3
is similar to those
calculated for the 3C proteases (20). These Vmax
values are relatively low compared with the type I and type II
substrates
-lactalbumin and
-lactoglobulin (20). Moreover, the
Vmax/Km ratio for the
ubiquitination of ribonuclease S is similar to the ratio found to
characterize the reactions with the 3C proteases.
-Lactalbumin and
-lactoglobulin are ubiquitinated in reactions characterized by
Vmax/Km ratios about 30- and
130-fold greater, respectively (20). This difference in
Vmax/Km values must reflect
the effect on E3
of the internal position of the recognized
destruction signal versus the N terminus of the substrate proteins.
-dependent ubiquitination
of three EMCV 3C protease proteins carrying pairs of lysine to
arginine substitutions yielded Km and
Vmax values both greater than for the wild type
protein. This result is something of a surprise, because it might be
expected that a reduction in the number of available lysine residues
would lower the kcat, and thereby the
Vmax, with which ubiquitin conjugation occurs.
One possible explanation for these results is that the selection of the
initial ubiquitin attachment site is a stochastic process (15), and the
active site of E3
transiently associates with several available
lysine residues until one in a favorable structural context is located.
Reducing the availability of less optimal lysine residues could perhaps
reduce the time required for E3
to locate favored ubiquitin
attachment sites. Alternatively, it may be that surface-exposed basic
amino acids are specifically involved in the discriminatory
interactions that take place between E3
and substrate proteins and
that E3
associates more effectively with arginine residues than with
lysines. It can be concluded, at least, that the ten-amino acid protein
destruction signal is not the only feature in the EMCV 3C protease
capable of modulating E3
activity. It is of interest to note that
changes in the basic amino acid composition of substrate proteins has
also been shown indirectly to affect the activity of yeast Ubr1p,
although it is unclear how these changes modulate Ubr1p-substrate
interactions (35).
interacts with these proteins through
a complicated mechanism and that substrate selection is not based
solely upon a simple recognition of the substrate to form a
ligase-substrate complex. Baboshina et al. (20) have proposed a model by which E3
interacts with at least two sites on
substrate proteins. Their data suggest that interactions between the
N-terminal amino acids of type I or type II N-end rule substrates and a
site on E3
promote the formation of a catalytically competent conformation of the ligase. This model predicts certain features of
type III substrates other than N-terminal amino acids also associate
with the N-terminal amino acid binding site and induce, though less
effectively, the formation of a catalytically active E3
. Our results
with the 3C proteases are consistent with this model. In the case of
the 3C proteins, the destruction signal motifs appear to regulate how
rapidly E3
can catalyze the conjugation of ubiquitin to the protease
proteins. The initial recognition of the 3C protease by E3
, as
defined by k
1/k1 in the
two-step reaction model, does not appear to contribute in a major way
to the observed differences in the overall rates of initial ubiquitin conjugation. That the 3C proteases must interact with the same site, or
sites, on E3
that binds basic or bulky N-terminal amino acids is
indicated by the fact that both lysylalanine and phenylalanylalanine inhibit the ubiquitination of both the EMCV and HAV 3C proteases. It is
conceivable that the hydrophobic and basic amino acids in the
destruction signals can mimic destabilizing N-terminal amino acids
during the association of the substrates with E3
. The 3C protease
destruction signals do not appear to be as effective as N-terminal
basic or bulky hydrophobic amino acids at stimulating E3
activity,
because the Vmax values for the
E3
-dependent ubiquitination of types I and II substrates
are much higher than for the formation of ubiquitin-3C protease
conjugates (20).
| |
FOOTNOTES |
|---|
* This work was supported in part by National Science Foundation Research in Undergraduate Institutions Award MCB-9974497 (to T. G. L.), a Henry Dreyfus Teacher Scholar Award (to T. G. L.), a Roger C. Schmutz Faculty Research Grant (to T. G. L.), and by United States Public Health Services Grant GM 34009 (to A. L. H.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ To whom correspondence should be addressed. Tel.: 207-786-6293; Fax: 207-786-8336; E-mail: tlawson@bates.edu.
Published, JBC Papers in Press, August 28, 2001, DOI 10.1074/jbc.M102659200
2 M. E. Sweep, T. G. Lawson, and A. L. Haas, unpublished results.
3 V. P. Losick, P. E. Schlax, R. E. Emmons, and T. G. Lawson, unpublished results.
4 The HsUbc2b is identical in sequence to its rabbit ortholog (27) and is functionally indistinguishable from the "a" isoform (26).
5 T. G. Lawson, unpublished results.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: E1, ubiquitin-activating enzyme; E2, ubiquitin carrier protein; E3, ubiquitin-protein ligase; EMCV, encephalomyocarditis virus; HAV, hepatitis A virus; PAGE, polyacrylamide gel electrophoresis.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Hershko, A., and Ciechanover, A. (1998) Annu. Rev. Biochem. 67, 425-497[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Pickart, C. M. (2001) Annu. Rev. Biochem. 70, 503-533[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Ciechanover, A., Orian, A., and Schwartz, A. L. (1999) Bioessays 22, 442-451 |
| 4. |
Finley, D.,
Sadis, S.,
Monia, B. P.,
Boucher, P.,
Ecker, D. J.,
Crooke, S. T.,
and Chau, V.
(1994)
Mol. Cell. Biol.
14,
5501-5509 |
| 5. | Laney, J. D., and Hochstrasser, M. (1999) Cell 97, 427-430[CrossRef][Medline] [Order article via Infotrieve] |
| 6. |
Reiss, Y.,
Heller, H.,
and Hershko, A.
(1989)
J. Biol. Chem.
264,
10378-10383 |
| 7. |
Haas, A. L.,
Reback, P. B.,
and Chau, V.
(1991)
J. Biol. Chem.
266,
5104-5112 |
| 8. |
Dohman, R. J.,
Madura, K.,
Bartel, B.,
and Varshavsky, A.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
7351-7355 |
| 9. | Xie, Y., and Varshavsky, A. (1999) EMBO J. 18, 6832-6844[CrossRef][Medline] [Order article via Infotrieve] |
| 10. |
Bachmair, A.,
Finley, D.,
and Varshavsky, A.
(1986)
Science
234,
179-186 |
| 11. |
Reiss, Y.,
Kaim, D.,
and Hershko, A.
(1988)
J. Biol. Chem.
263,
2693-2698 |
| 12. |
Gonda, D. K.,
Bachmair, A.,
Wünning, I.,
Tobias, J. W.,
Lane, W. S.,
and Varshavsky, A.
(1989)
J. Biol. Chem.
264,
16700-16712 |
| 13. |
Reiss, Y.,
and Hershko, A.
(1990)
J. Biol. Chem.
265,
3685-3690 |
| 14. |
Baker, R. T.,
and Varshavsky, A.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
1090-1094 |
| 15. |
Baker, R. T.,
and Varshavsky, A.
(1995)
J. Biol. Chem.
270,
12065-12074 |
| 16. |
Varshavsky, A.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
12142-12149 |
| 17. |
Madura, K.,
and Varshavsky, A.
(1994)
Science
265,
1454-1458 |
| 18. | Byrd, C., Turner, G. C., and Varshavsky, A. (1998) EMBO J. 17, 269-277[CrossRef][Medline] [Order article via Infotrieve] |
| 19. | Schauber, C., Chen, L., Tongaonkar, P., Vega, I., and Madura, K. (1998) Genes Cells 3, 307-319[Abstract] |
| 20. |
Baboshina, O. V.,
Crinelli, R.,
Siepmann, T. J.,
and Haas, A. L.
(2001)
J. Biol. Chem.
276,
39428-39437 |
| 21. | Gladding, R. L., Haas, A. L., Gronros, D. L., and Lawson, T. G. (1997) Biochem. Biophys. Res. Commun. 238, 119-125[CrossRef][Medline] [Order article via Infotrieve] |
| 22. |
Lawson, T. G.,
Gronros, D. L.,
Werner, J. A.,
Wey, A. C.,
DiGeorge, A. M.,
Lockhart, J. L.,
Wilson, J. W.,
and Wintrode, P. L.
(1994)
J. Biol. Chem.
269,
28429-28435 |
| 23. |
Lawson, T. G.,
Gronros, D. L.,
Evans, P. E.,
Bastien, M. C.,
Michalewich, K. M.,
Clark, J. K.,
Edmonds, J. H.,
Graber, K. H.,
Werner, J. A.,
Lurvey, B. A.,
and Cate, J. M.
(1999)
J. Biol. Chem.
274,
9871-9980 |
| 24. | Studier, F. W., Rosenberg, A. H., Dunn, J. J., and Dubendorff, J. E. (1990) Methods Enzymol. 185, 60-89[Medline] [Order article via Infotrieve] |
| 25. |
Hershko, A.,
Heller, H.,
Elias, S.,
and Ciechanover, A.
(1983)
J. Biol. Chem.
258,
8206-8214 |
| 26. |
Haas, A. L.,
and Bright, P. M.
(1988)
J. Biol. Chem.
263,
13258-13267 |
| 27. | Wing, S. S., Dumas, F., and Banville, D. (1992) J. Biol. Chem. 267, 6494-6501 |
| 28. | Anchordoguy, T. J., and Hand, S. C. (1995) J. Exp. Biol. 198, 1299-1305[Abstract] |
| 29. | Hershko, A., and Heller, H. (1985) Biochem. Biophys. Res. Commun. 128, 1079-1086[CrossRef][Medline] [Order article via Infotrieve] |
| 30. |
Haas, A. L.,
and Rose, I. A.
(1981)
Proc. Natl. Acad. Sci. U. S. A.
78,
6845-6848 |
| 31. |
Chau, V.,
Tobias, J. W.,
Bachmair, A.,
Marriot, D.,
Ecker, D.,
Gonda, D. K.,
and Varshavsky, A.
(1989)
Science
243,
1576-1583 |
| 32. |
Palmenberg, A. C.,
Kirby, E. M.,
Janda, M. R.,
Drake, N. L.,
Duke, G. M.,
Potratz, K. F.,
and Collett, M. S.
(1984)
Nucleic Acids Res.
12,
2969-2985 |
| 33. | Paul, A. V., Tada, H., von der Helm, K., Wissel, T., Kiehn, R., Wimmer, E., and Deinhardt, F. (1987) Virus Res. 8, 153-171[CrossRef][Medline] [Order article via Infotrieve] |
| 34. | Bergmann, E. M., Mosimann, S. C., Chernaia, M. M., Malcolm, B. A., and James, M. N. G. (1997) J. Virol. 71, 2436-2448[Abstract] |
| 35. | Suzuki, T., and Varshavsky, A. (1999) EMBO J. 18, 6017-6026[CrossRef][Medline] [Order article via Infotrieve] |